Trial intelligence / Profile preview

Mometasone/Formoterol vs Fluticasone/Salmeterol in Asthma

NCT02415179Completed

Sponsor
Mahidol University
Start
May 2015
Primary completion
Feb 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of mometasone and formoterol in asthma, sponsored by Mahidol University. Primary endpoint: Peripheral Airway Function (R5-R20) at 6 weeks. Started May 2015; status: completed.

02

Drugs

mometasoneformoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02415179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02415179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call